Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Abalone Bio, Inc in June, 2020 for $349,013.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK125191-01 | Phase I | 349,013 | June 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Abalone Bio, Inc in May, 2021 for $300,241.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK127654-01A1 | Phase I | 300,241 | May 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Abalone Bio, Inc in September, 2019 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA241513-01A1 | Phase I | 299,999 | September 25, 2019 | |||||||
A SBIR Phase II contract was awarded to Abalone Bio, Inc in May, 2021 for $915,873.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA241513-02 | Phase II | 915,873 | May 15, 2021 | |||||||
A SBIR Phase II contract was awarded to Abalone Bio, Inc in August, 2022 for $999,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK125191-02 | Phase II | 999,999 | August 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Abalone Bio, Inc in June, 2022 for $292,942.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HD106864-01A1 | Phase I | 292,942 | June 10, 2022 | |||||||
A SBIR Phase II contract was awarded to Abalone Bio, Inc in March, 2019 for $750,000.0 USD from the National Science Foundation. | SBIR | 1853147 | Phase II | 750,000 | March 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Abalone Bio, Inc in January, 2018 for $225,000.0 USD from the National Science Foundation. | SBIR | 1747391 | Phase I | 225,000 | January 1, 2018 |